Mineralys Therapeutics MLYS
NASDAQ MLYS
$15.52 -0.29 (-1.83%)
At close: Nov 10, 2026 · 4:00 PM EST

Mineralys Therapeutics (MLYS) Liabilities and Shareholders Equity (2021 - 2026)

Updated

Analysis

Mineralys Therapeutics (MLYS) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 Mineralys Therapeutics 1.37 Bn -1.21 Bn - 630.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 630.12 Mn
Jun 30, 2026 667.85 Mn
Mar 31, 2026 652.86 Mn
Dec 31, 2025 661.81 Mn
Sep 30, 2025 599.95 Mn
Jun 30, 2025 335.72 Mn
Mar 31, 2025 354.94 Mn
Dec 31, 2024 205.90 Mn
Sep 30, 2024 268.25 Mn
Jun 30, 2024 318.49 Mn
Mar 31, 2024 347.25 Mn
Dec 31, 2023 251.64 Mn
Sep 30, 2023 277.56 Mn
Jun 30, 2023 291.22 Mn
Mar 31, 2023 306.44 Mn
Dec 31, 2022 114.44 Mn
Dec 31, 2021 11.13 Mn
API Access

Mineralys Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=MLYS&period=max&api_key=YOUR_API_KEY